Cargando…

Prognostic histological factors in patients with esophageal squamous cell carcinoma after preoperative chemoradiation followed by surgery

BACKGROUND: Pathological response is an important marker for tumor aggressiveness in patients with esophageal squamous cell carcinoma (ESCC) who receive preoperative chemoradiation followed by esophagectomy. We aim to evaluate the prognostic value of histological factors after trimodality treatments...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Cheng-Che, Hsu, Po-Kuei, Chien, Ling-I, Liu, Wan-Chen, Huang, Chien-Sheng, Hsieh, Chih-Cheng, Hsu, Han-Shui, Wu, Yu-Chung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244588/ https://www.ncbi.nlm.nih.gov/pubmed/28103913 http://dx.doi.org/10.1186/s12885-017-3063-5

Ejemplares similares

The Prognostic Impact of Preoperative and Postoperative Chemoradiation in Clinical Stage II and III Esophageal Squamous Cell Carcinomas: A Population Based Study in Taiwan
por: Chen, Hui-Shan, et al.
Publicado: (2015)

Prognostic Effect of the Dose of Radiation Therapy and Extent of Lymphadenectomy in Patients Receiving Neoadjuvant Chemoradiotherapy for Esophageal Squamous Carcinoma
por: Pai, Chu-Pin, et al.
Publicado: (2022)

Preoperative consolidation‐to‐tumor ratio is effective in the prediction of lymph node metastasis in patients with pulmonary ground‐glass component nodules
por: Chen, Yi‐Chung, et al.
Publicado: (2021)

Prognostic histologic subtyping of dominant tumor in resected synchronous multiple adenocarcinomas of lung
por: Tsai, Ping-Chung, et al.
Publicado: (2021)

Overall Survival for Esophageal Squamous Cell Carcinoma with Multiple Primary Cancers after Curative Esophagectomy—A Retrospective Single-Institution Study
por: Tsai, Ping-Chung, et al.
Publicado: (2022)

Upfront surgery and pathological stage-based adjuvant chemoradiation strategy in locally advanced esophageal squamous cell carcinoma
por: Chen, Hui-Shan, et al.
Publicado: (2018)

Treatment Outcomes and Risk Factors for Incomplete Treatment after Definitive Chemoradiotherapy for Non-Resectable or Metastatic Esophageal Cancer
por: Pai, Chu-Pin, et al.
Publicado: (2023)

Clinical outcome of patients after recurrent laryngeal nerve lymph node dissection for oesophageal squamous cell carcinoma
por: Pai, Chu-Pin, et al.
Publicado: (2021)

Prognostication and optimal criteria of circumferential margin involvement for esophageal cancer after chemoradiation and esophagectomy
por: Potdar, Ankit, et al.
Publicado: (2023)

Histological Regression of Squamous Esophageal Carcinoma Assessed by Percentage of Residual Viable Cells after Neoadjuvant Chemoradiation is an Important Prognostic Factor
por: Tong, Daniel King Hung, et al.
Publicado: (2010)

A Retrospective Review of the Prognostic Value of ALDH-1, Bmi-1 and Nanog Stem Cell Markers in Esophageal Squamous Cell Carcinoma
por: Hwang, Cheng-Cheng, et al.
Publicado: (2014)

Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy
por: Tsai, Ping-Chung, et al.
Publicado: (2022)

FDG PET/CT and Endoscopic Ultrasound for Preoperative T-Staging of Esophageal Squamous Cell Carcinoma
por: Huang, Yung-Cheng, et al.
Publicado: (2023)

Outcomes of patients with different lepidic percentage and tumor size of stage I lung adenocarcinoma
por: Liu, Chia, et al.
Publicado: (2022)

Delayed surgery after histologic or radiologic-diagnosed clinical stage I lung adenocarcinoma
por: Huang, Chien-Sheng, et al.
Publicado: (2020)

Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma
por: Hsieh, Chih-Cheng, et al.
Publicado: (2016)

Complications after Chest Tube Removal and Reinterventions in Patients with Digital Drainage Systems
por: Lee, Yi-Ying, et al.
Publicado: (2019)

FDG PET using SUV(max) for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy
por: Huang, Yung-Cheng, et al.
Publicado: (2017)

Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation
por: Zhang, Chi, et al.
Publicado: (2023)

Total intravenous anesthesia decreases hospital stay but not incidence of postoperative pulmonary complications after lung resection surgery: a propensity score matching study
por: Hsu, Fu-Kai, et al.
Publicado: (2023)

Prognostic significance of lymph node ratio after neoadjuvant chemoradiation therapy for esophageal squamous cell carcinoma
por: Jang, Jeong Yun, et al.
Publicado: (2020)

Clinical significance of risk stratification of esophageal squamous cell carcinoma after neoadjuvant chemoradiation and surgery
por: Wu, Ya-hua, et al.
Publicado: (2021)

Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study)
por: Yang, Yang, et al.
Publicado: (2022)

ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma
por: Lin, Yu-Sen, et al.
Publicado: (2021)

Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm
por: Huang, Chien‐Sheng, et al.
Publicado: (2020)

Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
por: Matani, Hirsch, et al.
Publicado: (2022)

Nonintubated versus intubated “one-stage” preoperative localization and thoracoscopic lung resection
por: Hsu, Po-Kuei, et al.
Publicado: (2021)

Deep Convolutional Neural Network-Based Positron Emission Tomography Analysis Predicts Esophageal Cancer Outcome
por: Yang, Cheng-Kun, et al.
Publicado: (2019)

Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker In Predicting Pathological Response to Neoadjuvant Chemoradiation
por: Hsu, Feng-Ming, et al.
Publicado: (2015)

Preoperative serum lipids as prognostic predictors in esophageal squamous cell carcinoma patients with esophagectomy
por: Chen, Pengxiang, et al.
Publicado: (2017)

Lymphadenectomy is Unnecessary for Pure Ground-Glass Opacity Pulmonary Nodules
por: Lin, Yi-Han, et al.
Publicado: (2020)

Prognostic Significance of Serum Carcinoembryonic Antigen Normalization on Survival in Rectal Cancer Treated with Preoperative Chemoradiation
por: Chung, Mi-Joo, et al.
Publicado: (2013)

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
por: So, Tsz Him, et al.
Publicado: (2020)

Predicting aggressive histopathological features in esophageal cancer with positron emission tomography using a deep convolutional neural network
por: Yeh, Joe Chao-Yuan, et al.
Publicado: (2021)

Prognostic significance of preoperative IKBKE expression in esophageal squamous cell carcinoma
por: Yang, Wenjing, et al.
Publicado: (2018)

MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma
por: Lin, Cheng-Han, et al.
Publicado: (2016)

Radiotherapy Alone or Concurrent Chemoradiation for Esophageal Squamous Cell Carcinoma in Elderly Patients
por: Zhao, Lina, et al.
Publicado: (2017)

Prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy
por: Huang, Hui-Shan, et al.
Publicado: (2018)

AGR2 expression as a predictive biomarker for therapy response in esophageal squamous cell carcinoma
por: Lin, Chih-Hung, et al.
Publicado: (2022)

Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma
por: Du, Qingwu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kd2lnl2t1m53en3p7pvqv94d3i